CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Aug 23, 2017 12:00 pm UTC| Business
EDEN PRAIRIE, Minn., Aug. 23, 2017 -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on August 17, 2017, the Compensation Committee of the Board of Directors approved eleven equity awards under CHF Solution’s...
ATA Announces Subsidiary’s Shareholders Approve Voluntary New Third Board Delisting
Aug 23, 2017 12:00 pm UTC| Business
BEIJING, Aug. 23, 2017 -- ATA Inc. ("ATA" or the "Company") (Nasdaq:ATAI), a leading provider of advanced testing technologies and testing-related services in China, today announced that, on August 23, 2017,...
A-Mark Precious Metals to Present at the 6th Annual Liolios Gateway Conference on September 7, 2017
Aug 23, 2017 12:00 pm UTC| Business
EL SEGUNDO, Calif., Aug. 23, 2017 -- A-Mark Precious Metals, Inc. (NASDAQ:AMRK), a full-service precious metals trading company and an official distributor for all the major sovereign mints, has been invited to present...
Asure Software to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
Aug 23, 2017 11:45 am UTC| Business
AUSTIN, Texas, Aug. 23, 2017 -- Asure Software, Inc. (NASDAQ:ASUR), a leading provider of Human Capital Management (HCM) and workplace management software, has been invited to present at the 6th Annual Liolios Gateway...
BLM Technologies Partners with Panini to Expand Instant EMV Issuance Options
Aug 23, 2017 11:38 am UTC| Business
Minneapolis, Minn., Aug. 23, 2017 -- BLM Technologies, a leading single-source provider of payment, transaction and other financial institution hardware, digital signage, and information technology services, expanded...
ADMA Biologics to Present at Upcoming Investor Conferences
Aug 23, 2017 11:38 am UTC| Business
RAMSEY, N.J., Aug. 23, 2017 -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”), a vertically integrated biopharmaceutical and specialty immunoglobulin company that develops, manufactures and markets...
Incysus Scientific Co-Founder to Present at Immuno-Oncology Summit
Aug 23, 2017 11:30 am UTC| Business
HAMILTON, Bermuda, Aug. 23, 2017 -- Incysus, Ltd, a biopharmaceutical company focused on delivering an innovative γδ T cell immunotherapy for the treatment of cancers, announced that its collaborator and scientific...